MarketCap
Facebook
X
TelegramAnnual report 2024
added 02-27-2025
ACADIA Pharmaceuticals Total Inventories 2011-2026 | ACAD
Annual Total Inventories ACADIA Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91.7 M | 40.4 M | - | 14.1 M | 9.68 M | 6.34 M | 4.07 M | 5.25 M | 4.18 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 91.7 M | 4.07 M | 22 M |
Quarterly Total Inventories ACADIA Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 M | 11.6 M | - | 12.5 M | 13.2 M | 14.1 M | 14.3 M | 10.8 M | 10.3 M | 9.68 M | 9.68 M | 9.68 M | 9.68 M | 6.34 M | 6.34 M | 6.34 M | 6.34 M | 4.07 M | 4.07 M | 4.07 M | 4.07 M | 5.25 M | 5.25 M | 5.25 M | 5.25 M | 4.18 M | 4.18 M | 4.18 M | 4.18 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 14.3 M | 4.07 M | 7.71 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aptorum Group Limited
APM
|
39.1 K | $ 0.82 | 1.9 % | $ 4.47 M |  China |
 |
Aquestive Therapeutics
AQST
|
6.04 M | $ 4.18 | 2.32 % | $ 363 M |  USA |
 |
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | USA |
 |
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | USA |
 |
Axsome Therapeutics
AXSM
|
27.9 M | $ 165.2 | -2.79 % | $ 8.22 B | USA |
 |
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | USA |
 |
BeiGene, Ltd.
BGNE
|
495 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biogen
BIIB
|
2.17 B | $ 190.58 | -2.33 % | $ 27.9 B | USA |
 |
BioMarin Pharmaceutical
BMRN
|
1.23 B | $ 61.56 | -1.7 % | $ 11.7 B | USA |
 |
Baudax Bio
BXRX
|
5 M | - | 0.59 % | $ 63 K | USA |
 |
Amneal Pharmaceuticals
AMRX
|
612 M | $ 14.68 | 0.1 % | $ 4.54 B | USA |
 |
CASI Pharmaceuticals
CASI
|
1.91 M | $ 0.35 | -55.89 % | $ 47.6 M | USA |